Education And Debate Fortnightly Review: Drug treatment of Parkinson's disease BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6979.575 (Published 04 March 1995) Cite this as: BMJ 1995;310:575 Article Related content Metrics Responses Peer review Related articles Letter Anticholinergic drugs are not contraindicated after iridotomy Published: 24 June 1995; BMJ 310 doi:10.1136/bmj.310.6995.1668a See more Thiazide diuretics seem to protect against fracture BMJ November 22, 2016, 355 i6263; DOI: https://doi.org/10.1136/bmj.i6263 Steroid injections through the eardrum reduce dizziness in Meniere’s disease, study finds BMJ November 18, 2016, 355 i6185; DOI: https://doi.org/10.1136/bmj.i6185 Chronic insomnia: diagnosis and non-pharmacological management BMJ November 16, 2016, 355 i5819; DOI: https://doi.org/10.1136/bmj.i5819 Risks of duloxetine for stress incontinence outweigh benefits, say researchers BMJ November 15, 2016, 355 i6103; DOI: https://doi.org/10.1136/bmj.i6103 How changes to drug prohibition could be good for the UK—an essay by Molly Meacher and Nick Clegg BMJ November 14, 2016, 355 i6006; DOI: https://doi.org/10.1136/bmj.i6006 Cited by... Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcomeAbstract Fulltext PDF Pharmacological treatment of Parkinson's diseaseAbstract Fulltext PDF Dopamine agonists: their role in the treatment of Parkinson's diseaseAbstract Fulltext PDF Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow upAbstract Fulltext PDF Drugs for Parkinson's disease reviewedAbstract Fulltext PDF
